Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The drug is tested on the gut metagenome community of MV28 with study accession number: PRJEB31790 and sample accession number: SAMEA5537509 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
Assay data:4 Tested
Summary
The drug is tested on the gut metagenome community of MV27 with study accession number: PRJEB31790 and sample accession number: SAMEA5537508 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV26 with study accession number: PRJEB31790 and sample accession number: SAMEA5537507 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV25 with study accession number: PRJEB31790 and sample accession number: SAMEA5537506 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV24 with study accession number: PRJEB31790 and sample accession number: SAMEA5537505 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV23 with study accession number: PRJEB31790 and sample accession number: SAMEA5537504 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV22 with study accession number: PRJEB31790 and sample accession number: SAMEA5537503 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV21 with study accession number: PRJEB31790 and sample accession number: SAMEA5537502 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV20 with study accession number: PRJEB31790 and sample accession number: SAMEA5537501 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV19 with study accession number: PRJEB31790 and sample accession number: SAMEA5537500 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV18 with study accession number: PRJEB31790 and sample accession number: SAMEA5537499 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV17 with study accession number: PRJEB31790 and sample accession number: SAMEA5537498 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV16 with study accession number: PRJEB31790 and sample accession number: SAMEA5537497 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV15 with study accession number: PRJEB31790 and sample accession number: SAMEA5537496 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV14 with study accession number: PRJEB31790 and sample accession number: SAMEA5537495 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV13 with study accession number: PRJEB31790 and sample accession number: SAMEA5537494 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV12 with study accession number: PRJEB31790 and sample accession number: SAMEA5537493 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV11 with study accession number: PRJEB31790 and sample accession number: SAMEA5537492 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV10 with study accession number: PRJEB31790 and sample accession number: SAMEA5537491 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
The drug is tested on the gut metagenome community of MV09 with study accession number: PRJEB31790 and sample accession number: SAMEA5537490 for biotransformation. The drug concentrations were measured over 9 timepoints collected between 0 and 24 hours of incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on